GlassScriptPhysician profile
Darshan Rajendra Patel
NPI 1386930139
$884.85
in general payments reported to CMS, 2019-2025
16 companies · $366 in 2025
The $366 reported for 2025 was more than what 76% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $14.78 · 2022: $121 · 2023: $50.00 · 2024: $137 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $195.95 | 2019 | |
| Pfizer INC. | $141.47 | 2025 | |
| Progenics Pharmaceuticals, INC. | $100.96 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $69.50 | 2024-2025 | Libtayo |
| Novartis Pharmaceuticals Corporation | $54.85 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $46.99 | 2022-2025 | Reblozyl, Keytruda |
| Exelixis INC. | $44.97 | 2025 | Cabometyx |
| Incyte Corporation | $42.64 | 2023-2024 | Jakafi, Monjuvi, Pemazyre |
| Karyopharm Therapeutics INC. | $41.23 | 2023-2025 | Xpovio |
| Eisai INC. | $28.79 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.88 | 2025 | |
| Legend Biotech USA INC. | $22.03 | 2025 | Carvykti |
| Sun Pharmaceutical Industries INC. | $20.78 | 2024 | |
| Spectrum Pharmaceuticals INC. | $17.70 | 2025 | Rolvedon |
| Alexion Pharmaceuticals, INC. | $17.33 | 2023 | Ultomiris |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darshan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.